Tyler Bartholomew, Ph.D., is director of the Division of Health Services Research and Policy and an associate professor in the Department of Public Health Sciences at the University of Miami Miller School of Medicine. He also serves as co-principal investigator of the IDEA Lab, which implements, disseminates and evaluates programs designed to improve the health of people who use drugs.
Dr. Bartholomew’s research focuses on the infectious complications of substance use, particularly among people who inject drugs. He uses data-driven and community-engaged approaches to strengthen health services, systems and policies. He led research and evaluation efforts for the IDEA Miami Syringe Services Program, the first legal syringe services program in Florida. This work helped inform statewide legislation enacted in 2019 that authorized Florida counties to establish syringe services programs.
His research has received support from the National Institutes of Health, the Centers for Disease Control and Prevention and Gilead Sciences. He is also an investigator in the National Institute on Drug Abuse-funded Clinical Trials Network Florida Node Alliance.
Through a partnership with the Florida Harm Reduction Collective, Dr. Bartholomew supports the statewide adoption, implementation and sustainability of syringe services programs. He also serves on the organization’s board of directors.
